Infliximab maintenance therapy for fistualising Crohn's disease
by Sands, B.
Physical details: 876-885
Subject(s):
Crohn's disease
| Item type | Current location | Call number | Vol info | Copy number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|---|
Journals, eBooks, Papers, Articles, Magazines
|
350, 9, 26 February, 2004. | 1 | Available |
Journal print article
Patients with fistualising Crohn's disease have an increased likelihood of a continued response over a 54 week period if infliximab treatment is continued every 8 weeks. 3 tabs 2 figs.
There are no comments for this item.